Your browser doesn't support javascript.
loading
[Comparison of therapeutic efficacy of Wuling Capsules prepared with different methods for rats with syndrome of liver Qi stagnation, spleen deficiency, and blood stasis].
Hui, Yu-Jing; Yu, Jin-Gao; Tang, Zhi-Shu; Wang, Mei; Song, Zhong-Xing; Liu, Hong-Na; Zhou, Jian-Ping; Cao, Zhao-Jun.
Afiliação
  • Hui YJ; Shaanxi Collaborative Innovation Center of Chinese Medicine Resources Industrialization/State Key Laboratory of Research& Development of Characteristic Qin Medicine Resources (Cultivation)/Shaanxi Innovative Drug Research Center, Shaanxi University of Chinese Medicine Xianyang 712046, China.
  • Yu JG; Shaanxi Collaborative Innovation Center of Chinese Medicine Resources Industrialization/State Key Laboratory of Research& Development of Characteristic Qin Medicine Resources (Cultivation)/Shaanxi Innovative Drug Research Center, Shaanxi University of Chinese Medicine Xianyang 712046, China.
  • Tang ZS; Shaanxi Collaborative Innovation Center of Chinese Medicine Resources Industrialization/State Key Laboratory of Research& Development of Characteristic Qin Medicine Resources (Cultivation)/Shaanxi Innovative Drug Research Center, Shaanxi University of Chinese Medicine Xianyang 712046, China Chin
  • Wang M; Shaanxi Collaborative Innovation Center of Chinese Medicine Resources Industrialization/State Key Laboratory of Research& Development of Characteristic Qin Medicine Resources (Cultivation)/Shaanxi Innovative Drug Research Center, Shaanxi University of Chinese Medicine Xianyang 712046, China.
  • Song ZX; Shaanxi Collaborative Innovation Center of Chinese Medicine Resources Industrialization/State Key Laboratory of Research& Development of Characteristic Qin Medicine Resources (Cultivation)/Shaanxi Innovative Drug Research Center, Shaanxi University of Chinese Medicine Xianyang 712046, China.
  • Liu HN; Tsing Hua De Ren Xi'an Happiness Pharmaceutical Co., Ltd. Xi'an 710043, China.
  • Zhou JP; Tsing Hua De Ren Xi'an Happiness Pharmaceutical Co., Ltd. Xi'an 710043, China.
  • Cao ZJ; Tsing Hua De Ren Xi'an Happiness Pharmaceutical Co., Ltd. Xi'an 710043, China.
Zhongguo Zhong Yao Za Zhi ; 47(23): 6380-6390, 2022 Dec.
Article em Zh | MEDLINE | ID: mdl-36604883
ABSTRACT
Wuling Capsules is one of the commonly used drugs for the clinical treatment of chronic hepatitis B with the syndrome of liver Qi stagnation, spleen deficiency, and blood stasis. However, the present preparation method of Wuling Capsules ignores some macromolecules like polysaccharides. In this study, the influences of different ethanol concentrations in the preparation process on the extraction rates of macro-and micro-molecules were investigated. Further, the therapeutic efficacy of Wuling Capsules was evaluated with the reserpine-induced rat model of liver Qi stagnation, spleen deficiency, and blood stasis. When 50% ethanol was used for the last time of extraction, the concentrations of polysaccharides, salvianolic acid B, and schisandrin in the extract, as well as the dry extract yield, increased significantly compared with those of the original preparation method. However, the fingerprints of micro-molecules showed little difference between the two methods, with a similarity of 0.862. The study then set the 50% ethanol extraction as the new preparation method. The pharmacodynamics evaluation showed that the Wuling Capsules prepared with the original and new methods both significantly alleviated the emotional depression and metabolic disturbance in model rats, demonstrating good performance in protecting the rats against gastric mucosal injuries, modulating intestinal function, and activating blood circulation. The mechanism of action may be related to the regulation of gastrointestinal hormone secretion, reduction of inflammation, and promotion of dopamine synthesis in cortex and hippocampus. At the same dose, the Wuling Capsules prepared with the original and new methods showed roughly the same overall therapeutic efficacy. However, the Wuling Capsules prepared with the new method had stronger effect in activating blood circulation and modulating inflammation, but weaker effects in regulating gastrin and dopamine. The present study provides basis data for optimizing the preparation process of Wuling Capsules and deciphering the mechanism of its therapeutic effect on liver Qi stagnation, spleen deficiency, and blood stasis.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Qi / Medicina Tradicional Chinesa Tipo de estudo: Diagnostic_studies Limite: Animals Idioma: Zh Revista: Zhongguo Zhong Yao Za Zhi Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Qi / Medicina Tradicional Chinesa Tipo de estudo: Diagnostic_studies Limite: Animals Idioma: Zh Revista: Zhongguo Zhong Yao Za Zhi Ano de publicação: 2022 Tipo de documento: Article